Probenecid Administration for Alcohol Craving and Consumption (NCT07118618)

🧪 Interventions in This Study

• Probenecid Oral Tablet (DRUG)
• Placebo Oral Tablet (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (1 Sites)

• Brown University — Providence, Rhode Island

📞 Contact the Study Coordinator

Phone: (401) 863-6646

Email: brian_gully@brown.edu

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Alcohol Use Disorder (AUD)

• PsiloStudy: Psilocybin With Psychological Support (Psi-PS) for Military Veterans and First Responders With Co-occurring PTSD & Alcohol Use Disorder (AUD) — Seattle, Washington
• Ibudilast for Treating Alcohol Use Disorder — Philadelphia, Pennsylvania
• The Zonisamide and Reinforcement for Reducing Alcohol Use (ZARRA) Study — Spokane, Washington
• Semaglutide Dose Effects on Metabolic and Stress Hormone, Craving and Alcohol Use Outcomes — New Haven, Connecticut
• Social Identity Mapping for Adolescent Recovery — Boston, Massachusetts
• Cannabidiol as an Adjunct Treatment for Alcohol Withdrawal and Craving — Baltimore, Maryland

Explore by condition: All Alcohol Use Disorder (AUD) clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.